Sponsors
Find a Sponsor
Browse: All | Federal | Private | State | UW
Department of Defense, U.S. (DOD)
Access Useful Pages on the Sponsor Site
Newly Added Opportunities from the Department of Defense, U.S.
- DoD Prostate Cancer Postdoctoral Training Award [...]
View on Grants.gov Funding Opportunity Number: W81XWH-13-PCRP-PTA Opportunity Category: Discretionary Funding Instrument Type: Cooperative Agreement
GrantCategory of Funding Activity: Science and Technology and other Research and Development CFDA Number: 12.420 Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" Agency Name: DOD-AMRAA Closing Date: Sep 05, 2013 Award Ceiling: $0 Expected Number of Awards: 31 Creation Date: Jun 15, 2013 Funding Opportunity Description: The PCRP Postdoctoral Training Award mechanism was first offered as the Postdoctoral Traineeship Award in FY99 and was incorporated into the Prostate Cancer Training Award in FY06-FY10. In total, 1,306 Postdoctoral Training Award applications have been received, and 429 have been recommended for funding. The Postdoctoral Training Award supports prostate cancer research training opportunities for recent doctoral graduates. These awards primarily provide salary support for the Principal Investigator (PI); the postdoctoral trainee is considered the PI of the application. The PI must exhibit strong potential for, and commitment to, pursuing a career as an investigator at the forefront of prostate cancer research; however, the PI is not required to have previous prostate cancer research experience. Applications must include at least one mentor, appropriate to the proposed training and research project, who has experience in prostate cancer research and training as demonstrated by a record of funding, publications, and successful mentorship. The selected mentor(s) should demonstrate a clear commitment to the PIs training and be well qualified to contribute significantly to the development of the PI toward independence as a prostate cancer researcher. The PI must outline an individualized, prostate cancer-focused training plan, which may include coursework, laboratory techniques, conferences, seminars, journal clubs, teaching responsibilities, clinical responsibilities, grant writing, and/or other activities that will provide the PI with experience in key areas relevant to the proposed work and foster the PIs development as an independent prostate cancer researcher. An environment appropriate to the proposed training and research project must be clearly described. All applications for the Postdoctoral Training Award are to be written by the PI, with appropriate direction from the mentor(s). The PCRP seeks applications from the wide spectrum of basic, population science, translational, and clinical research. In addition, applicants are expected to address at least one of the PCRP focus areas and are highly encouraged to address one of the PCRP overarching challenges. If the proposed project does not address any of the overarching challenges, the application should include a description to justify how the project will nevertheless address a critical need in the field of prostate cancer research and/or patient care. All investigators applying to FY13 PCRP funding opportunities are encouraged to consider leveraging resources available through the PCRP-funded Prostate Cancer Biorepository Network (PCBN) (http://www.prostatebiorepository.org) and/or the North Carolina - Louisiana Prostate Cancer Project (PCaP) (http://www.ncla-pcap.org) if retrospectively collected human anatomical substances or correlated data are relevant to the proposed studies. The Congressionally Directed Medical Research Programs (CDMRP) intends that data and research resources generated under awards funded by this Program Announcement/Funding Opportunity be made available to the research community (which includes both scientific and consumer advocacy communities) and to the public at large. For additional guidance, refer to the General Application Instructions, Appendix 4, Section K. - DoD Prostate Cancer Exploration-Hypothesis Development Award [...]
View on Grants.gov Funding Opportunity Number: W81XWH-13-PCRP-EHDA Opportunity Category: Discretionary Funding Instrument Type: Cooperative Agreement
GrantCategory of Funding Activity: Science and Technology and other Research and Development CFDA Number: 12.420 Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" Agency Name: DOD-AMRAA Closing Date: Jul 31, 2013 Award Ceiling: $0 Expected Number of Awards: 25 Creation Date: Jun 15, 2013 Funding Opportunity Description: The PCRP Exploration - Hypothesis Development Award mechanism was first offered in FY03. Since then, 1,814 Exploration - Hypothesis Development Award applications have been received, and 209 have been recommended for funding. The Exploration - Hypothesis Development Award supports the exploration of highly innovative, untested, potentially high-gain concepts, theories, paradigms, and/or methods that address an important problem in prostate cancer. Results of studies conducted through this award may provide the scientific rationale upon which a new hypothesis can be based or initial proof-of-principle of an innovative hypothesis. This award is designed to provide investigators the opportunity to pursue serendipitous observations that may reveal entirely new avenues for investigation. Presentation of preliminary data is inconsistent with the intent of this award mechanism and is therefore strongly discouraged. However, logical reasoning and a sound scientific rationale for the proposed work must be described. The PCRP seeks applications from the wide spectrum of basic, population science, translational, and clinical research. In addition, applicants are expected to address at least one of the PCRP focus areas and are highly encouraged to address one of the PCRP overarching challenges. If the proposed project does not address any of the overarching challenges, the application should include a description to justify how the project will nevertheless address a critical need in the field of prostate cancer research and/or patient care. Research involving human subjects is encouraged under this funding opportunity but is restricted to studies without clinical trials. Correlative studies associated with an existing clinical trial are allowed if they are determined to be no greater than minimal risk by the local IRB of record and the U.S. Army Medical Research and Materiel Command (USAMRMC) Office of Research Protections (ORP), Human Research Protection Office (HRPO). Projects involving human subjects or specimens must be exempt under 32 CFR 219.101(b) or eligible for expedited review (32 CFR 219.110 or 21 CFR 56.110). Additional information on the protection of human subjects and exempt or expedited review status can be found at https://www.bids.tswg.gov/. For definitions and other information on clinical trials and clinical research overall, a Human Subject Resource Document is provided on the CDMRP eReceipt System at https://cdmrp.org/Program_Announcements_and_Forms/. All investigators applying to FY13 PCRP funding opportunities are encouraged to consider leveraging resources available through the PCRP-funded Prostate Cancer Biorepository Network (PCBN) (http://www.prostatebiorepository.org) and/or the North Carolina - Louisiana Prostate Cancer Project (PCaP) (http://www.ncla-pcap.org) if retrospectively collected human anatomical substances or correlated data are relevant to the proposed studies. The Congressionally Directed Medical Research Programs (CDMRP) intends that data and research resources generated under awards funded by this Program Announcement/Funding Opportunity be made available to the research community (which includes both scientific and consumer advocacy communities) and to the public at large. For additional guidance, refer to the General Application Instructions, Appendix 4, Section K. - DoD Prostate Cancer Population Science Impact Award [...]
View on Grants.gov Funding Opportunity Number: W81XWH-13-PCRP-PSIA Opportunity Category: Discretionary Funding Instrument Type: Cooperative Agreement
GrantCategory of Funding Activity: Science and Technology and other Research and Development CFDA Number: 12.420 Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" Agency Name: DOD-AMRAA Closing Date: Oct 09, 2013 Award Ceiling: $0 Expected Number of Awards: 2 Creation Date: Jun 15, 2013 Funding Opportunity Description: The PCRP Population Science Impact Award (PSIA) mechanism was first offered as the Population-Based Idea Development Award in FY09 and Population-Based Research Award in FY10 and FY11. In total, 62 applications have been received, and 4 have been recommended for funding. The Population Science Impact Award mechanism supports high-impact, population science approaches to prostate cancer research. Applications should clearly demonstrate the potential of the study to contribute significantly to the elimination of death from prostate cancer and/or enhancing the well-being of men experiencing the impact of the disease. As such, studies should address one of the PCRP overarching challenges, or, alternatively, justify the study as addressing another critical area in prostate cancer research. In addition, studies are expected to address one or more of the PCRP focus areas; for the PSIA, projects focused on the following are particularly encouraged: biomarkers, especially those relevant to aggressive disease; genetics/ genomics; therapy and predictors of response or resistance; and survivorship and palliative care. Studies that, in whole or in part, address disparities in prostate cancer incidence, morbidity, or mortality, are also encouraged. The overall goal of this award is to generate data and/or tools that can only be achieved from the perspective of systematic studies focused on specific populations of individuals, rather than specific individuals. Such studies will be built upon the logic, concepts, and methods of one or more population sciences including but not limited to: Epidemiology Surveillance Health services research Outcomes research Behavioral science Social science Dissemination research The outcomes for research supported through this award mechanism will have the potential for substantial impact for men with or at risk for prostate cancer within, for example, epidemiologic cohorts, defined communities, or health systems. Applications may propose retrospective, prospective, case control, cohort, or other population science study designs (including the use of biospecimens and data from established retrospective databases), provided the proposed sample is of sufficient size to demonstrate statistical significance. The study should address a well-developed hypothesis that is conceptually sound and specific for prostate cancer. The statistical expertise of the study team should be clearly described and evident in the study plan. Applicants are expected to provide documentation demonstrating access to, and ability to recruit as applicable, the appropriate population(s), patient samples, datasets in numbers sufficient to achieve statistical significance. Research involving human subject use is permitted under this funding opportunity, but is restricted to studies without clinical trials; however, correlative studies with populations from existing clinical trials, are allowed. For definitions and other information on clinical trials and clinical research overall, a Human Subject Resource Document is provided on the CDMRP eReceipt System at https://cdmrp.org/Program_Announcements_and_Forms/. All investigators applying to FY13 PCRP funding opportunities are encouraged to consider leveraging resources available through the PCRP-funded Prostate Cancer Biorepository Network (PCBN) (http://www.prostatebiorepository.org) and/or the North Carolina Louisiana Prostate Cancer Project (PCaP) (http://www.ncla-pcap.org), if retrospectively collected human anatomical substances or correlated data are relevant to the proposed studies. The CDMRP intends that data and research resources generated under awards funded by this Program Announcement/Funding Opportunity be made available to the research community (which includes both scientific and consumer advocacy communities) and to the public at large. For additional guidance, refer to the General Application Instructions, Appendix 4, Section K. - DoD Prostate Cancer Dr. Barbara Terry-Koroma Health Disparity Research Award [...]
View on Grants.gov Funding Opportunity Number: W81XWH-13-PCRP-HDRA Opportunity Category: Discretionary Funding Instrument Type: Cooperative Agreement
GrantCategory of Funding Activity: Science and Technology and other Research and Development CFDA Number: 12.420 Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" Agency Name: DOD-AMRAA Closing Date: Oct 09, 2013 Award Ceiling: $0 Expected Number of Awards: 5 Creation Date: Jun 15, 2013 Funding Opportunity Description: The PCRP Health Disparity Research Award (HDRA) mechanism was introduced in FY01. Since then, 308 applications have been received, and 62 have been recommended for funding. The HDRA supports new ideas based on innovative concepts or methodologies for prostate cancer health disparity research with the potential to make an important contribution toward eliminating death from prostate cancer and enhancing the well-being of men impacted by the disease. Studies proposed for this award mechanism are expected to improve the understanding of, and ultimately contribute to eliminating, disparities in prostate cancer incidence, morbidity, and mortality. Applicants for this award must explicitly state how the proposed research is related to an area of prostate cancer health disparity. Appropriate health disparity areas include, but are not limited to, race and ethnicity, socioeconomic status, access to or differing standards of health care, insurance status, age, geography, and cultural beliefs. The PCRP seeks HDRA applications from the wide spectrum of basic, population science, translational, and clinical research, provided they are appropriately focused on an issue of prostate cancer health disparity. In addition, all applications are expected to be relevant to one or more of the PCRP focus areas and are encouraged to be responsive to one of the PCRP overarching challenges. If the proposed project does not address one of the overarching challenges, the application must provide a description to justify how the project will nevertheless address a critical disparity-related need in the field of prostate cancer research and/or patient care. Research involving human subject use is permitted under this funding opportunity, but is restricted to studies without clinical trials; however, correlative studies, including studies with populations from existing clinical trials, are allowed. For definitions and other information on clinical trials and clinical research overall, a Human Subject Resource Document is provided on the CDMRP eReceipt System at https://cdmrp.org/Program_Announcements_and_Forms/. The Health Disparity Research Award offers three additional options for PI consideration: 1. Qualified Collaborator Option: The HDRA strongly supports collaborative research involving basic, population science, and clinical researchers, researchers with prostate cancer expertise and those with health disparity expertise, and/or researchers and community organizations that may be critical to the study of populations disproportionately affected by prostate cancer. Although these and other types of collaborations are, in general, strongly encouraged, collaborations that meet specific criteria will qualify for a higher level of funding as described in Section I.D., Funding. For the application to qualify for a higher level of funding, the PI must submit a Qualified Collaboration Statement that clearly describes the proposed collaborator and collaboration and addresses how each of the criteria below are met. In addition, the collaborator must provide a letter of collaboration describing his/her involvement in the proposed work. It should be clear from both documents that the successful completion of the project depends on the unique skills and contributions of both the PI and the qualified collaborator. The following criteria must be met to use the Qualified Collaborator Option: The collaborator must significantly contribute to the project such that the proposed work could not be accomplished without his/her involvement. This is expected to include both intellectual input and research resources (e.g., supplies, reagents, equipment, personnel, services, tissue samples, or access to patients or populations). The collaborator must contribute at least a 10% level of effort to the project. Contribution of the collaborator should be reflected in the application budget. If the PI does not have experience in prostate cancer research or working with disproportionately affected populations, the collaborator must possess such experience. 2. New Investigator Option: The HDRA mechanism encourages applications from investigators in the early stages of their careers. The New Investigator Option is designed to allow PIs, early in their faculty appointments or in the process of developing independent research careers, to compete for funding separately from established investigators. Applications from New Investigators and Established Investigators will be peer and programmatically reviewed separately. PIs using the New Investigator Option are strongly encouraged to strengthen their applications by including investigators experienced in prostate cancer research and/or possessing other relevant expertise as demonstrated by a record of funding and publications. It is the responsibility of the PI to describe how additional investigators will augment his/her expertise and better address the research question. PIs may choose to employ both the New Investigator Option and the Qualified Collaborator Option in a single application. All applicants for the New Investigator Option must meet specific eligibility criteria as described in Section I.C., Eligibility Information. 3. Nested Health Disparity Traineeship Option: The HDRA offers opportunities for training highly motivated graduate students and postdoctoral fellows interested in pursuing a career in resolving disparities in prostate cancer incidence, morbidity, and mortality. The trainee is not required to have previous health disparity or prostate cancer research experience. This option primarily provides salary support for the trainee. An individualized training program in prostate cancer disparities must be described, and may include coursework, laboratory techniques, conferences, seminars, journal clubs, teaching responsibilities, clinical responsibilities, grant writing and/or other activities that will provide the trainee with experience in key areas relevant to the proposed work and foster the trainees development as a prostate cancer health disparity researcher. An environment appropriate to the proposed training must be clearly described. Only one traineeship (predoctoral or postdoctoral) may be requested per application. Plans for training and mentorship must be well developed and clearly described by the PI for the HDRA application. - DoD Prostate Cancer Physician Research Training Award [...]
View on Grants.gov Funding Opportunity Number: W81XWH-13-PCRP-PRTA Opportunity Category: Discretionary Funding Instrument Type: Cooperative Agreement
GrantCategory of Funding Activity: Science and Technology and other Research and Development CFDA Number: 12.420 Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" Agency Name: DOD-AMRAA Closing Date: Sep 05, 2013 Award Ceiling: $0 Expected Number of Awards: 5 Creation Date: Jun 15, 2013 Funding Opportunity Description: The PCRP Physician Research Training Award (PRTA) mechanism was first offered in FY03. Since then, 154 PRTA applications have been received, and 63 have been recommended for funding. The PRTA supports a mentored training experience to prepare physicians with clinical duties and/or responsibilities for productive careers in prostate cancer research. This award emphasizes equally the quality of both the research and the training proposed. The trainee is considered the Principal Investigator (PI) of the application. All applications for the PRTA are to be written by the PI, with appropriate direction from the mentor(s). The PI must demonstrate a commitment to a career as an investigator at the forefront of prostate cancer research and clinical practice; however, the PI is not required to have previous prostate cancer research experience. Applications must include a robust description of an individualized, prostate cancer-focused training plan that will provide the PI with experience in key areas relevant to the proposed work and foster the PIs development as a prostate cancer researcher. PIs who already possess extensive experience in cancer research may not be viewed as fitting the intent of this award mechanism. This award requires the involvement of at least one designated mentor with an established research program in prostate cancer, evidenced by publications, funding, and successful mentorship. The PI and mentor(s) should work together to design robust training and mentoring plans, which may include coursework, laboratory techniques, conferences, seminars, journal clubs, teaching responsibilities, clinical responsibilities, grant writing, and/or other activities appropriate to the area of study. Training plans that will prepare physicians for careers in basic or population science research are particularly encouraged, although inclusion of translational or clinical research is allowed. In addition, applicants are expected to address at least one of the PCRP focus areas and are highly encouraged to address one of the PCRP overarching challenges. If the proposed project does not address any of the overarching challenges, the application should include a description to justify how the project will nevertheless address a critical need in the field of prostate cancer research and/or patient care. This award is intended to provide aggressive protection of at least 40% of the PIs time for prostate cancer research. In addition, salary for up to a 50% combined level of effort from up to two key support personnel may be provided by this award. Up to $15,000 in funds per year from this award may be used for research supplies and equipment. These funds may be used for research with laboratory animals and human biological substances, as well as research with human subjects, provided that the funds are not used to support clinical trials. PIs may participate in clinical trials as part of their training for this award, but funding for such clinical trials must come from sources other than this award. All investigators applying to FY13 PCRP funding opportunities are encouraged to consider leveraging resources available through the PCRP-funded Prostate Cancer Biorepository Network (PCBN) (http://www.prostatebiorepository.org) and/or the North Carolina - Louisiana Prostate Cancer Project (PCaP) (http://www.ncla-pcap.org) if retrospectively collected human anatomical substances or correlated data are relevant to the proposed studies. The Congressionally Directed Medical Research Programs (CDMRP) intends that data and research resources generated under awards funded by this Program Announcement/Funding Opportunity be made available to the research community (which includes both scientific and consumer advocacy communities) and to the public at large. For additional guidance, refer to the General Application Instructions, Appendix 4, Section K.
Recently Modified Opportunities from the Department of Defense, U.S.
- 2013 NAWCAD STEM Education Grant [...]
View on Grants.gov Funding Opportunity Number: NAWCAD-13-1-0002 Opportunity Category: Discretionary Funding Instrument Type: Grant Category of Funding Activity: Education CFDA Number: Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification) Agency Name: DOD-ONR-AIR Closing Date: Jul 03, 2013 Award Ceiling: $5,000 Expected Number of Awards: 8 Creation Date: Jun 18, 2013 Funding Opportunity Description: The Naval Air Systems Command (NAVAIR) education outreach program offers an opportunity for schools with formal or pending education partnership agreements in place with the Lakehurst, New Jersey organization (also known as the Naval Air Warfare Center, Aircraft Division, Lakehurst), to submit an application for the 2013 Science, Technology, Engineering and Mathematics (STEM) Education Grants Program. These competitive grants are designed to increase innovation in science, technology, engineering and mathematics programs only for students grades 4 12 in Ocean and Burlington Counties in New Jersey. Funding opportunities associated with this grant are in the following categories:(a)Costs associated with a field trip to the Naval Air Systems Command Lakehurst Facility to reinforce STEM curriculum Includes transportation, substitute teacher (if needed) and other associated costs. (b)Costs associated with teacher participation in a STEM education program or conference. Includes travel expenses (transportation, lodging and per diem) and conference registration. (c)Robotics competition participation in the 2013/2014 and/or 2014/2015 school years. Includes registration and associated costs. Robotics competitions include, but are not limited to, FIRST (www.usfirst.org), SEA PERCH (www.seaperch.org) and ZEX (www.vexrobotics.com). - DoD Peer Reviewed Medical Discovery Award [...]
View on Grants.gov Funding Opportunity Number: W81XWH-13-PRMRP-DA Opportunity Category: Discretionary Funding Instrument Type: Cooperative Agreement
GrantCategory of Funding Activity: Science and Technology and other Research and Development CFDA Number: 12.420 Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" Agency Name: DOD-AMRAA Closing Date: Aug 06, 2013 Award Ceiling: Expected Number of Awards: 20 Creation Date: Jun 17, 2013 Funding Opportunity Description: The intent of the PRMRP Discovery Award is to support innovative, untested, high-risk/ potentially high-reward concepts, theories, paradigms, and/or methods. Studies supported by this award are expected to lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design. The proposed research project should be novel and innovative. Innovative research may introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. Research that is an incremental advance upon published data is not considered innovative and is not consistent with the intent of this award mechanism. - DoD Prostate Cancer Collaborative Undergraduate HBCU Student Summer Training Program Award [...]
View on Grants.gov Funding Opportunity Number: W81XWH-13-PCRP-STPA Opportunity Category: Discretionary Funding Instrument Type: Cooperative Agreement
GrantCategory of Funding Activity: Science and Technology and other Research and Development CFDA Number: 12.420 Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" Agency Name: DOD-AMRAA Closing Date: Sep 05, 2013 Award Ceiling: $0 Expected Number of Awards: 5 Creation Date: Jun 17, 2013 Funding Opportunity Description: The PCRP Collaborative Undergraduate HBCU1 Student Summer Training Program Award (STPA) mechanism was first offered in FY04. Since then, 58 STPA applications have been received, and 36 have been recommended for funding. The STPA supports the training of the next generation of prostate cancer researchers. This award funds new or existing summer training programs in prostate cancer research for undergraduate students from Historically Black Colleges and Universities (HBCU) at host institutions with ongoing prostate cancer research. Training programs are highly encouraged to include, among the projects proposed, exposure to and/or experiences in prostate cancer health disparity research. This award also requires the Program Director [designated as the Principal Investigator (PI)], who should be an established prostate cancer researcher at the host institution, to collaborate with faculty advisors from the undergraduate trainees HBCU. Applicants must enroll a minimum of four undergraduate HBCU trainees per year, who may be recruited from multiple HBCU. The PIs institution, which may also be an HBCU, must have a record of achievement in prostate cancer research and in research training. When the PIs institution is an HBCU, the undergraduate trainees must be recruited from different HBCU. A goal of this award is to establish or strengthen collaborations between the PIs institution and the undergraduate trainees HBCU, which will foster the recruitment of talented trainees from the HBCU to the PIs institutional prostate cancer training program. It is expected that these awards will provide educational and training opportunities for undergraduate HBCU students at an important decision-making point in their careers. Applications for this award should address the following key aspects for the proposed prostate cancer training program: The qualifications of the PI and other program faculty and staff who will serve as collaborating mentors, including their track records in training undergraduate students; The proposed training program for the undergraduate HBCU trainees at the PIs institution, including research projects, seminars/symposia, coursework, etc.; 1For purposes of this program announcement, the term HBCU is used to indicate a single institution or multiple institutions. The plans for recruitment of undergraduate HBCU trainees and for continued interaction of the PI with the trainees beyond the summer internship period; The qualifications and roles of the faculty advisor(s) at the trainees HBCU, who will be responsible for working with the PI to coordinate trainee activities during both the summer training program and throughout the corresponding academic year. In addition, proposed training programs are expected to address at least one of the PCRP focus areas and are highly encouraged to address one of the PCRP overarching challenges. Trainees must spend 8 to 12 weeks during the summer participating in the program at the PIs institution. The trainees in this program can be named or designated to be named (TBN) at the time of application submission; however, the criteria for selection of the trainees at the HBCU must be described in detail within the applications project narrative. Although a single individual must be clearly designated as the PI, it is expected that the application will name and describe the qualifications of multiple mentors. The mentor(s) must show a commitment to the undergraduate trainees HBCU through a plan to provide additional mentoring opportunities to participating trainees at the institution beyond the summer internship period. All investigators applying to FY13 PCRP funding opportunities are encouraged to consider leveraging resources available through the PCRP-funded Prostate Cancer Biorepository Network (PCBN) (http://www.prostatebiorepository.org) and/or the North Carolina - Louisiana Prostate Cancer Project (PCaP) (http://www.ncla-pcap.org) if retrospectively collected human anatomical substances or correlated data are relevant to the proposed studies. The Congressionally Directed Medical Research Programs (CDMRP) intends that data and research resources generated under awards funded by this Program Announcement/Funding Opportunity be made available to the research community (which includes both scientific and consumer advocacy communities) and to the public at large. For additional guidance, refer to the General Application Instructions, Appendix 4, Section K. - AFRL Research Collaboration Program [...]
View on Grants.gov Funding Opportunity Number: BAA-RQKM-2013-0005 Opportunity Category: Discretionary Funding Instrument Type: Cooperative Agreement
Grant
Procurement ContractCategory of Funding Activity: Science and Technology and other Research and Development CFDA Number: 12.800 Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" Agency Name: DOD-AFRL Closing Date: Dec 20, 2017 Award Ceiling: Expected Number of Awards: 40 Creation Date: Jun 17, 2013 Funding Opportunity Description: The objective of the AFRL Research Collaboration program is to enable collaborative research partnerships between AFRL and Academia and Industry in areas including but not limited to Materials and Manufacturing and Aerospace Sensors that engage a diverse pool of domestic businesses that employ scientists and engineers in technical areas required to develop critical war-fighting technologies for the nations air, space and cyberspace forces through specific AFRL Core Technical Competencies (CTCs). - Arrays at Commercial Timescales (ACT) [...]
View on Grants.gov Funding Opportunity Number: DARPA-BAA-13-26 Opportunity Category: Discretionary Funding Instrument Type: Cooperative Agreement
Grant
Other
Procurement ContractCategory of Funding Activity: Science and Technology and other Research and Development CFDA Number: 12.910 Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" Agency Name: DOD-DARPA-MTO Closing Date: Jun 19, 2013 Award Ceiling: $0 Expected Number of Awards: Creation Date: Jun 17, 2013 Funding Opportunity Description: Amendment 02: The purpose of this amendment is to extend the proposal due date due to TFIMS system connectivity issues being experienced today (6/17/13). Amendment 01: The purpose of this amendment is to incorporate technical revisions to DARPA-BAA-13-26 and to make an administrative change to Attachment 1. Please see the revisions highlighted in yellow in the attached conformed DARPA-BAA-13-26 documents (to include Attachment 1). Original Synopsis below. ACT aims to dramatically shorten the timescales associated with electromagnetic array development, deployment and upgrade. Specifically, this program will depart from traditional highly-specialized and time-consuming array design methodologies and focus on three enabling thrust areas: 1) realization of a common hardware module that can be broadly applied to many disparate array functions, 2) development of a reconfigurable electromagnetic interface capable of supporting a wide variety of parameters such as different polarizations, frequencies, bandwidths, etc. and 3) demonstration of a scalable infrastructure in which arrays on physically disconnected platforms can be coherently combined into a larger effective aperture through the use of precise timing and localization data. See the full DARPA-BAA-13-26 document attached.
| 
